Advanced Drug Delivery Markets (Liposomes, Polymers and Monoclonal Antibodies)
Growth in biological drugs and gene therapy is driving developments in the advanced drug delivery market. A report from healthcare market research publisher Kalorama Information, Advanced Drug Delivery Markets (Liposomes, Polymers and Monoclonal Antibodies), finds that nanotechnology is the most promising area in the $60.6 billion global market for advanced drug delivery products.
Advanced drug delivery strategies are taking advantage of new entities in therapeutic pharmacology, such as proteins and peptides and other novel compounds that target drugs to specific disease sites. For Example, gene therapy has shown promise, but its development is stymied by the lack of appropriate delivery methods.
"The goal of advanced drug delivery systems is to deploy medications intact to specifically targeted parts of the body through a medium that can control the therapy's administration by means of a physiological chemical trigger," said Melissa Elder, an analyst for Kalorama Information and the author of the study. "To achieve this goal, researchers are turning to advances in micro and nanotechnology."
During the last decade, polymeric microspheres, polymer micelles, and hydrogel-type nanocarriers have all been shown to be effective in enhancing drug targeting specificity, lowering drug toxicity, improving treatment absorption rates, and providing protection for drugs against biochemical degradation.
"Some areas of nanotechnology are more advanced than others," said Elder. "However, all are playing a large role in diagnostics, pharmaceuticals and therapeutics."
Kalorama finds sales in nanomedicine are expected to spike with the highly anticipated development of monoclonal antibodies for respiratory indications, psoriasis, prevention of transplant rejection and cancer. Over twenty companies have patents in this area of development, indicating a propitious future outlook. With an increasing number of disease and cancer patients, pharmaceutical companies are facing a difficult challenge in the delivery of breakthrough medications. There is an immense revenue opportunity in nanotechnology capable of providing targeted drug delivery.
Advanced Drug Delivery Markets (Liposomes, Polymers and Monoclonal Antibodies) analyzes several trends, including molecular imprinted polymers, antibiotic biodegradable implants, hot-melt extrusion technology, sorbent technology, and gene therapy drug delivery. The report concentrates on liposome and polymer drug delivery, as well as monoclonal antibodies.
More Drug Delivery reports by Kalorama Information
The World Market for Implantable and Needle-Free Drug Delivery Systems by Kalorama Information
This report, The World Market for Implantable and Needle-Free Drug Delivery details the types of drug delivery systems and technologies that are being used in ...
The World Market for Transdermal Drug Delivery by Kalorama Information
Transdermal (and related transmucosal) drug delivery is a well-established accepted route of administration for therapeutically beneficial medicines. There is no potential limit for the ...
Outsourcing in Drug Development: The Contract CRO, Clinical Trial Lab and EDC Market by Kalorama Information
The cost and time of developing and bringing a drug to market is over $1.3 billion and often takes as long as 15 years, if ...
Needle-Free Drug Delivery: The Market for Alternatives to Needle-Based Systems for Vaccines and Biologics by Kalorama InformationSee all reports like this >>
As researchers work to improve drug properties through drug design and molecular modeling, the line between drug delivery and drug substance will become more and ...
Drug Delivery Reports